nodes	percent_of_prediction	percent_of_DWPC	metapath
Allopurinol—gout—ankylosing spondylitis	0.763	1	CtDrD
Allopurinol—AOX1—Methotrexate—ankylosing spondylitis	0.0859	0.544	CbGbCtD
Allopurinol—SLC22A7—Methotrexate—ankylosing spondylitis	0.0447	0.283	CbGbCtD
Allopurinol—SLC22A8—Methotrexate—ankylosing spondylitis	0.0273	0.173	CbGbCtD
Allopurinol—Arthralgia—Methylprednisolone—ankylosing spondylitis	8.37e-05	0.00106	CcSEcCtD
Allopurinol—Eye disorder—Prednisone—ankylosing spondylitis	8.36e-05	0.00106	CcSEcCtD
Allopurinol—Drowsiness—Methotrexate—ankylosing spondylitis	8.33e-05	0.00106	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	8.31e-05	0.00106	CcSEcCtD
Allopurinol—Depression—Methotrexate—ankylosing spondylitis	8.3e-05	0.00105	CcSEcCtD
Allopurinol—Flushing—Prednisone—ankylosing spondylitis	8.3e-05	0.00105	CcSEcCtD
Allopurinol—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	8.3e-05	0.00105	CcSEcCtD
Allopurinol—Ill-defined disorder—Betamethasone—ankylosing spondylitis	8.3e-05	0.00105	CcSEcCtD
Allopurinol—Discomfort—Triamcinolone—ankylosing spondylitis	8.29e-05	0.00105	CcSEcCtD
Allopurinol—Discomfort—Methylprednisolone—ankylosing spondylitis	8.27e-05	0.00105	CcSEcCtD
Allopurinol—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	8.26e-05	0.00105	CcSEcCtD
Allopurinol—Angioedema—Betamethasone—ankylosing spondylitis	8.17e-05	0.00104	CcSEcCtD
Allopurinol—Angioedema—Dexamethasone—ankylosing spondylitis	8.17e-05	0.00104	CcSEcCtD
Allopurinol—Stomatitis—Methotrexate—ankylosing spondylitis	8.12e-05	0.00103	CcSEcCtD
Allopurinol—Conjunctivitis—Methotrexate—ankylosing spondylitis	8.1e-05	0.00103	CcSEcCtD
Allopurinol—Confusional state—Methylprednisolone—ankylosing spondylitis	8.09e-05	0.00103	CcSEcCtD
Allopurinol—Immune system disorder—Prednisone—ankylosing spondylitis	8.08e-05	0.00103	CcSEcCtD
Allopurinol—Malaise—Dexamethasone—ankylosing spondylitis	8.06e-05	0.00102	CcSEcCtD
Allopurinol—Malaise—Betamethasone—ankylosing spondylitis	8.06e-05	0.00102	CcSEcCtD
Allopurinol—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	8.04e-05	0.00102	CcSEcCtD
Allopurinol—Oedema—Triamcinolone—ankylosing spondylitis	8.04e-05	0.00102	CcSEcCtD
Allopurinol—Vertigo—Dexamethasone—ankylosing spondylitis	8.03e-05	0.00102	CcSEcCtD
Allopurinol—Vertigo—Betamethasone—ankylosing spondylitis	8.03e-05	0.00102	CcSEcCtD
Allopurinol—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	8.03e-05	0.00102	CcSEcCtD
Allopurinol—Infection—Triamcinolone—ankylosing spondylitis	7.99e-05	0.00101	CcSEcCtD
Allopurinol—Sweating—Methotrexate—ankylosing spondylitis	7.98e-05	0.00101	CcSEcCtD
Allopurinol—Infection—Methylprednisolone—ankylosing spondylitis	7.97e-05	0.00101	CcSEcCtD
Allopurinol—Haematuria—Methotrexate—ankylosing spondylitis	7.94e-05	0.00101	CcSEcCtD
Allopurinol—Insomnia—Prednisolone—ankylosing spondylitis	7.91e-05	0.001	CcSEcCtD
Allopurinol—Alopecia—Prednisone—ankylosing spondylitis	7.91e-05	0.001	CcSEcCtD
Allopurinol—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	7.88e-05	0.001	CcSEcCtD
Allopurinol—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	7.87e-05	0.000999	CcSEcCtD
Allopurinol—Epistaxis—Methotrexate—ankylosing spondylitis	7.86e-05	0.000997	CcSEcCtD
Allopurinol—Paraesthesia—Prednisolone—ankylosing spondylitis	7.85e-05	0.000997	CcSEcCtD
Allopurinol—Mental disorder—Prednisone—ankylosing spondylitis	7.84e-05	0.000995	CcSEcCtD
Allopurinol—Skin disorder—Methylprednisolone—ankylosing spondylitis	7.8e-05	0.00099	CcSEcCtD
Allopurinol—Malnutrition—Prednisone—ankylosing spondylitis	7.79e-05	0.000989	CcSEcCtD
Allopurinol—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	7.78e-05	0.000987	CcSEcCtD
Allopurinol—Agranulocytosis—Methotrexate—ankylosing spondylitis	7.77e-05	0.000987	CcSEcCtD
Allopurinol—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	7.76e-05	0.000985	CcSEcCtD
Allopurinol—Convulsion—Dexamethasone—ankylosing spondylitis	7.75e-05	0.000984	CcSEcCtD
Allopurinol—Convulsion—Betamethasone—ankylosing spondylitis	7.75e-05	0.000984	CcSEcCtD
Allopurinol—Hypertension—Dexamethasone—ankylosing spondylitis	7.72e-05	0.00098	CcSEcCtD
Allopurinol—Hypertension—Betamethasone—ankylosing spondylitis	7.72e-05	0.00098	CcSEcCtD
Allopurinol—Myalgia—Betamethasone—ankylosing spondylitis	7.61e-05	0.000966	CcSEcCtD
Allopurinol—Myalgia—Dexamethasone—ankylosing spondylitis	7.61e-05	0.000966	CcSEcCtD
Allopurinol—Discomfort—Betamethasone—ankylosing spondylitis	7.52e-05	0.000955	CcSEcCtD
Allopurinol—Discomfort—Dexamethasone—ankylosing spondylitis	7.52e-05	0.000955	CcSEcCtD
Allopurinol—Haemoglobin—Methotrexate—ankylosing spondylitis	7.51e-05	0.000954	CcSEcCtD
Allopurinol—Hypotension—Methylprednisolone—ankylosing spondylitis	7.5e-05	0.000952	CcSEcCtD
Allopurinol—Pain—Prednisolone—ankylosing spondylitis	7.48e-05	0.000949	CcSEcCtD
Allopurinol—Haemorrhage—Methotrexate—ankylosing spondylitis	7.48e-05	0.000949	CcSEcCtD
Allopurinol—Hepatitis—Methotrexate—ankylosing spondylitis	7.48e-05	0.000949	CcSEcCtD
Allopurinol—Pharyngitis—Methotrexate—ankylosing spondylitis	7.42e-05	0.000942	CcSEcCtD
Allopurinol—Urinary tract disorder—Methotrexate—ankylosing spondylitis	7.38e-05	0.000937	CcSEcCtD
Allopurinol—Urethral disorder—Methotrexate—ankylosing spondylitis	7.33e-05	0.00093	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	7.33e-05	0.00093	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	7.31e-05	0.000928	CcSEcCtD
Allopurinol—Anaphylactic shock—Betamethasone—ankylosing spondylitis	7.3e-05	0.000926	CcSEcCtD
Allopurinol—Oedema—Dexamethasone—ankylosing spondylitis	7.3e-05	0.000926	CcSEcCtD
Allopurinol—Oedema—Betamethasone—ankylosing spondylitis	7.3e-05	0.000926	CcSEcCtD
Allopurinol—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	7.3e-05	0.000926	CcSEcCtD
Allopurinol—Insomnia—Triamcinolone—ankylosing spondylitis	7.28e-05	0.000924	CcSEcCtD
Allopurinol—Insomnia—Methylprednisolone—ankylosing spondylitis	7.26e-05	0.000921	CcSEcCtD
Allopurinol—Infection—Betamethasone—ankylosing spondylitis	7.25e-05	0.00092	CcSEcCtD
Allopurinol—Infection—Dexamethasone—ankylosing spondylitis	7.25e-05	0.00092	CcSEcCtD
Allopurinol—Ill-defined disorder—Prednisone—ankylosing spondylitis	7.23e-05	0.000917	CcSEcCtD
Allopurinol—Paraesthesia—Triamcinolone—ankylosing spondylitis	7.22e-05	0.000917	CcSEcCtD
Allopurinol—Feeling abnormal—Prednisolone—ankylosing spondylitis	7.21e-05	0.000915	CcSEcCtD
Allopurinol—Paraesthesia—Methylprednisolone—ankylosing spondylitis	7.21e-05	0.000915	CcSEcCtD
Allopurinol—Visual impairment—Methotrexate—ankylosing spondylitis	7.21e-05	0.000915	CcSEcCtD
Allopurinol—Anaemia—Prednisone—ankylosing spondylitis	7.2e-05	0.000914	CcSEcCtD
Allopurinol—Nervous system disorder—Dexamethasone—ankylosing spondylitis	7.16e-05	0.000909	CcSEcCtD
Allopurinol—Nervous system disorder—Betamethasone—ankylosing spondylitis	7.16e-05	0.000909	CcSEcCtD
Allopurinol—Agitation—Prednisone—ankylosing spondylitis	7.16e-05	0.000908	CcSEcCtD
Allopurinol—Thrombocytopenia—Betamethasone—ankylosing spondylitis	7.15e-05	0.000907	CcSEcCtD
Allopurinol—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	7.15e-05	0.000907	CcSEcCtD
Allopurinol—Angioedema—Prednisone—ankylosing spondylitis	7.12e-05	0.000903	CcSEcCtD
Allopurinol—Dyspepsia—Triamcinolone—ankylosing spondylitis	7.08e-05	0.000899	CcSEcCtD
Allopurinol—Erythema multiforme—Methotrexate—ankylosing spondylitis	7.07e-05	0.000897	CcSEcCtD
Allopurinol—Dyspepsia—Methylprednisolone—ankylosing spondylitis	7.06e-05	0.000897	CcSEcCtD
Allopurinol—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	7.06e-05	0.000896	CcSEcCtD
Allopurinol—Hyperhidrosis—Betamethasone—ankylosing spondylitis	7.06e-05	0.000896	CcSEcCtD
Allopurinol—Malaise—Prednisone—ankylosing spondylitis	7.02e-05	0.000892	CcSEcCtD
Allopurinol—Vertigo—Prednisone—ankylosing spondylitis	7e-05	0.000888	CcSEcCtD
Allopurinol—Eye disorder—Methotrexate—ankylosing spondylitis	6.99e-05	0.000887	CcSEcCtD
Allopurinol—Tinnitus—Methotrexate—ankylosing spondylitis	6.97e-05	0.000885	CcSEcCtD
Allopurinol—Anorexia—Dexamethasone—ankylosing spondylitis	6.96e-05	0.000883	CcSEcCtD
Allopurinol—Anorexia—Betamethasone—ankylosing spondylitis	6.96e-05	0.000883	CcSEcCtD
Allopurinol—Urticaria—Prednisolone—ankylosing spondylitis	6.95e-05	0.000882	CcSEcCtD
Allopurinol—Cardiac disorder—Methotrexate—ankylosing spondylitis	6.94e-05	0.000881	CcSEcCtD
Allopurinol—Pain—Triamcinolone—ankylosing spondylitis	6.88e-05	0.000873	CcSEcCtD
Allopurinol—Hypotension—Betamethasone—ankylosing spondylitis	6.82e-05	0.000866	CcSEcCtD
Allopurinol—Hypotension—Dexamethasone—ankylosing spondylitis	6.82e-05	0.000866	CcSEcCtD
Allopurinol—Immune system disorder—Methotrexate—ankylosing spondylitis	6.75e-05	0.000857	CcSEcCtD
Allopurinol—Convulsion—Prednisone—ankylosing spondylitis	6.75e-05	0.000857	CcSEcCtD
Allopurinol—Hypertension—Prednisone—ankylosing spondylitis	6.72e-05	0.000854	CcSEcCtD
Allopurinol—Chills—Methotrexate—ankylosing spondylitis	6.71e-05	0.000852	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	6.65e-05	0.000844	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	6.65e-05	0.000844	CcSEcCtD
Allopurinol—Arthralgia—Prednisone—ankylosing spondylitis	6.63e-05	0.000842	CcSEcCtD
Allopurinol—Myalgia—Prednisone—ankylosing spondylitis	6.63e-05	0.000842	CcSEcCtD
Allopurinol—Feeling abnormal—Triamcinolone—ankylosing spondylitis	6.63e-05	0.000841	CcSEcCtD
Allopurinol—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	6.61e-05	0.00084	CcSEcCtD
Allopurinol—Alopecia—Methotrexate—ankylosing spondylitis	6.61e-05	0.000839	CcSEcCtD
Allopurinol—Insomnia—Betamethasone—ankylosing spondylitis	6.6e-05	0.000838	CcSEcCtD
Allopurinol—Insomnia—Dexamethasone—ankylosing spondylitis	6.6e-05	0.000838	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	6.58e-05	0.000836	CcSEcCtD
Allopurinol—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	6.56e-05	0.000833	CcSEcCtD
Allopurinol—Paraesthesia—Dexamethasone—ankylosing spondylitis	6.55e-05	0.000832	CcSEcCtD
Allopurinol—Paraesthesia—Betamethasone—ankylosing spondylitis	6.55e-05	0.000832	CcSEcCtD
Allopurinol—Discomfort—Prednisone—ankylosing spondylitis	6.55e-05	0.000832	CcSEcCtD
Allopurinol—Mental disorder—Methotrexate—ankylosing spondylitis	6.55e-05	0.000831	CcSEcCtD
Allopurinol—Malnutrition—Methotrexate—ankylosing spondylitis	6.51e-05	0.000826	CcSEcCtD
Allopurinol—Hypersensitivity—Prednisolone—ankylosing spondylitis	6.44e-05	0.000818	CcSEcCtD
Allopurinol—Dyspepsia—Dexamethasone—ankylosing spondylitis	6.42e-05	0.000816	CcSEcCtD
Allopurinol—Dyspepsia—Betamethasone—ankylosing spondylitis	6.42e-05	0.000816	CcSEcCtD
Allopurinol—Urticaria—Triamcinolone—ankylosing spondylitis	6.39e-05	0.000811	CcSEcCtD
Allopurinol—Urticaria—Methylprednisolone—ankylosing spondylitis	6.38e-05	0.000809	CcSEcCtD
Allopurinol—Dysgeusia—Methotrexate—ankylosing spondylitis	6.37e-05	0.000809	CcSEcCtD
Allopurinol—Body temperature increased—Triamcinolone—ankylosing spondylitis	6.36e-05	0.000807	CcSEcCtD
Allopurinol—Oedema—Prednisone—ankylosing spondylitis	6.36e-05	0.000807	CcSEcCtD
Allopurinol—Anaphylactic shock—Prednisone—ankylosing spondylitis	6.36e-05	0.000807	CcSEcCtD
Allopurinol—Abdominal pain—Methylprednisolone—ankylosing spondylitis	6.34e-05	0.000805	CcSEcCtD
Allopurinol—Decreased appetite—Dexamethasone—ankylosing spondylitis	6.34e-05	0.000805	CcSEcCtD
Allopurinol—Decreased appetite—Betamethasone—ankylosing spondylitis	6.34e-05	0.000805	CcSEcCtD
Allopurinol—Infection—Prednisone—ankylosing spondylitis	6.31e-05	0.000802	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	6.3e-05	0.0008	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	6.3e-05	0.0008	CcSEcCtD
Allopurinol—Pain—Betamethasone—ankylosing spondylitis	6.24e-05	0.000792	CcSEcCtD
Allopurinol—Pain—Dexamethasone—ankylosing spondylitis	6.24e-05	0.000792	CcSEcCtD
Allopurinol—Nervous system disorder—Prednisone—ankylosing spondylitis	6.23e-05	0.000791	CcSEcCtD
Allopurinol—Skin disorder—Prednisone—ankylosing spondylitis	6.17e-05	0.000784	CcSEcCtD
Allopurinol—Hyperhidrosis—Prednisone—ankylosing spondylitis	6.14e-05	0.00078	CcSEcCtD
Allopurinol—Anorexia—Prednisone—ankylosing spondylitis	6.06e-05	0.000769	CcSEcCtD
Allopurinol—Ill-defined disorder—Methotrexate—ankylosing spondylitis	6.04e-05	0.000767	CcSEcCtD
Allopurinol—Anaemia—Methotrexate—ankylosing spondylitis	6.02e-05	0.000764	CcSEcCtD
Allopurinol—Feeling abnormal—Betamethasone—ankylosing spondylitis	6.01e-05	0.000763	CcSEcCtD
Allopurinol—Feeling abnormal—Dexamethasone—ankylosing spondylitis	6.01e-05	0.000763	CcSEcCtD
Allopurinol—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	5.97e-05	0.000758	CcSEcCtD
Allopurinol—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	5.97e-05	0.000758	CcSEcCtD
Allopurinol—Hypersensitivity—Triamcinolone—ankylosing spondylitis	5.93e-05	0.000752	CcSEcCtD
Allopurinol—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	5.91e-05	0.000751	CcSEcCtD
Allopurinol—Malaise—Methotrexate—ankylosing spondylitis	5.87e-05	0.000745	CcSEcCtD
Allopurinol—Vertigo—Methotrexate—ankylosing spondylitis	5.85e-05	0.000742	CcSEcCtD
Allopurinol—Leukopenia—Methotrexate—ankylosing spondylitis	5.83e-05	0.00074	CcSEcCtD
Allopurinol—Urticaria—Dexamethasone—ankylosing spondylitis	5.8e-05	0.000736	CcSEcCtD
Allopurinol—Urticaria—Betamethasone—ankylosing spondylitis	5.8e-05	0.000736	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	5.79e-05	0.000735	CcSEcCtD
Allopurinol—Dizziness—Prednisolone—ankylosing spondylitis	5.78e-05	0.000734	CcSEcCtD
Allopurinol—Asthenia—Triamcinolone—ankylosing spondylitis	5.77e-05	0.000733	CcSEcCtD
Allopurinol—Abdominal pain—Betamethasone—ankylosing spondylitis	5.77e-05	0.000732	CcSEcCtD
Allopurinol—Abdominal pain—Dexamethasone—ankylosing spondylitis	5.77e-05	0.000732	CcSEcCtD
Allopurinol—Body temperature increased—Betamethasone—ankylosing spondylitis	5.77e-05	0.000732	CcSEcCtD
Allopurinol—Body temperature increased—Dexamethasone—ankylosing spondylitis	5.77e-05	0.000732	CcSEcCtD
Allopurinol—Asthenia—Methylprednisolone—ankylosing spondylitis	5.76e-05	0.000731	CcSEcCtD
Allopurinol—Insomnia—Prednisone—ankylosing spondylitis	5.75e-05	0.00073	CcSEcCtD
Allopurinol—Paraesthesia—Prednisone—ankylosing spondylitis	5.71e-05	0.000724	CcSEcCtD
Allopurinol—Pruritus—Triamcinolone—ankylosing spondylitis	5.69e-05	0.000722	CcSEcCtD
Allopurinol—Pruritus—Methylprednisolone—ankylosing spondylitis	5.68e-05	0.000721	CcSEcCtD
Allopurinol—Convulsion—Methotrexate—ankylosing spondylitis	5.64e-05	0.000716	CcSEcCtD
Allopurinol—Dyspepsia—Prednisone—ankylosing spondylitis	5.59e-05	0.00071	CcSEcCtD
Allopurinol—Arthralgia—Methotrexate—ankylosing spondylitis	5.54e-05	0.000703	CcSEcCtD
Allopurinol—Myalgia—Methotrexate—ankylosing spondylitis	5.54e-05	0.000703	CcSEcCtD
Allopurinol—Decreased appetite—Prednisone—ankylosing spondylitis	5.53e-05	0.000701	CcSEcCtD
Allopurinol—Rash—Prednisolone—ankylosing spondylitis	5.52e-05	0.0007	CcSEcCtD
Allopurinol—Dermatitis—Prednisolone—ankylosing spondylitis	5.51e-05	0.000699	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	5.5e-05	0.000699	CcSEcCtD
Allopurinol—Diarrhoea—Methylprednisolone—ankylosing spondylitis	5.49e-05	0.000697	CcSEcCtD
Allopurinol—Headache—Prednisolone—ankylosing spondylitis	5.48e-05	0.000696	CcSEcCtD
Allopurinol—Discomfort—Methotrexate—ankylosing spondylitis	5.47e-05	0.000695	CcSEcCtD
Allopurinol—Constipation—Prednisone—ankylosing spondylitis	5.44e-05	0.00069	CcSEcCtD
Allopurinol—Confusional state—Methotrexate—ankylosing spondylitis	5.36e-05	0.00068	CcSEcCtD
Allopurinol—Dizziness—Triamcinolone—ankylosing spondylitis	5.32e-05	0.000675	CcSEcCtD
Allopurinol—Anaphylactic shock—Methotrexate—ankylosing spondylitis	5.31e-05	0.000674	CcSEcCtD
Allopurinol—Dizziness—Methylprednisolone—ankylosing spondylitis	5.31e-05	0.000674	CcSEcCtD
Allopurinol—Infection—Methotrexate—ankylosing spondylitis	5.28e-05	0.00067	CcSEcCtD
Allopurinol—Feeling abnormal—Prednisone—ankylosing spondylitis	5.24e-05	0.000665	CcSEcCtD
Allopurinol—Asthenia—Betamethasone—ankylosing spondylitis	5.24e-05	0.000665	CcSEcCtD
Allopurinol—Asthenia—Dexamethasone—ankylosing spondylitis	5.24e-05	0.000665	CcSEcCtD
Allopurinol—Nervous system disorder—Methotrexate—ankylosing spondylitis	5.21e-05	0.000661	CcSEcCtD
Allopurinol—Thrombocytopenia—Methotrexate—ankylosing spondylitis	5.2e-05	0.00066	CcSEcCtD
Allopurinol—Gastrointestinal pain—Prednisone—ankylosing spondylitis	5.2e-05	0.00066	CcSEcCtD
Allopurinol—Nausea—Prednisolone—ankylosing spondylitis	5.2e-05	0.00066	CcSEcCtD
Allopurinol—Pruritus—Betamethasone—ankylosing spondylitis	5.16e-05	0.000655	CcSEcCtD
Allopurinol—Pruritus—Dexamethasone—ankylosing spondylitis	5.16e-05	0.000655	CcSEcCtD
Allopurinol—Skin disorder—Methotrexate—ankylosing spondylitis	5.16e-05	0.000655	CcSEcCtD
Allopurinol—Hyperhidrosis—Methotrexate—ankylosing spondylitis	5.14e-05	0.000652	CcSEcCtD
Allopurinol—Vomiting—Triamcinolone—ankylosing spondylitis	5.11e-05	0.000649	CcSEcCtD
Allopurinol—Vomiting—Methylprednisolone—ankylosing spondylitis	5.1e-05	0.000648	CcSEcCtD
Allopurinol—Rash—Triamcinolone—ankylosing spondylitis	5.07e-05	0.000644	CcSEcCtD
Allopurinol—Dermatitis—Triamcinolone—ankylosing spondylitis	5.07e-05	0.000643	CcSEcCtD
Allopurinol—Anorexia—Methotrexate—ankylosing spondylitis	5.06e-05	0.000643	CcSEcCtD
Allopurinol—Rash—Methylprednisolone—ankylosing spondylitis	5.06e-05	0.000642	CcSEcCtD
Allopurinol—Dermatitis—Methylprednisolone—ankylosing spondylitis	5.06e-05	0.000642	CcSEcCtD
Allopurinol—Urticaria—Prednisone—ankylosing spondylitis	5.05e-05	0.000641	CcSEcCtD
Allopurinol—Headache—Triamcinolone—ankylosing spondylitis	5.04e-05	0.00064	CcSEcCtD
Allopurinol—Headache—Methylprednisolone—ankylosing spondylitis	5.03e-05	0.000638	CcSEcCtD
Allopurinol—Body temperature increased—Prednisone—ankylosing spondylitis	5.02e-05	0.000638	CcSEcCtD
Allopurinol—Abdominal pain—Prednisone—ankylosing spondylitis	5.02e-05	0.000638	CcSEcCtD
Allopurinol—Diarrhoea—Dexamethasone—ankylosing spondylitis	4.99e-05	0.000634	CcSEcCtD
Allopurinol—Diarrhoea—Betamethasone—ankylosing spondylitis	4.99e-05	0.000634	CcSEcCtD
Allopurinol—Hypotension—Methotrexate—ankylosing spondylitis	4.96e-05	0.00063	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	4.84e-05	0.000614	CcSEcCtD
Allopurinol—Dizziness—Dexamethasone—ankylosing spondylitis	4.83e-05	0.000613	CcSEcCtD
Allopurinol—Dizziness—Betamethasone—ankylosing spondylitis	4.83e-05	0.000613	CcSEcCtD
Allopurinol—Insomnia—Methotrexate—ankylosing spondylitis	4.8e-05	0.00061	CcSEcCtD
Allopurinol—Nausea—Triamcinolone—ankylosing spondylitis	4.78e-05	0.000606	CcSEcCtD
Allopurinol—Paraesthesia—Methotrexate—ankylosing spondylitis	4.77e-05	0.000605	CcSEcCtD
Allopurinol—Nausea—Methylprednisolone—ankylosing spondylitis	4.77e-05	0.000605	CcSEcCtD
Allopurinol—Somnolence—Methotrexate—ankylosing spondylitis	4.72e-05	0.000599	CcSEcCtD
Allopurinol—Hypersensitivity—Prednisone—ankylosing spondylitis	4.68e-05	0.000594	CcSEcCtD
Allopurinol—Dyspepsia—Methotrexate—ankylosing spondylitis	4.68e-05	0.000594	CcSEcCtD
Allopurinol—Vomiting—Betamethasone—ankylosing spondylitis	4.64e-05	0.000589	CcSEcCtD
Allopurinol—Vomiting—Dexamethasone—ankylosing spondylitis	4.64e-05	0.000589	CcSEcCtD
Allopurinol—Decreased appetite—Methotrexate—ankylosing spondylitis	4.62e-05	0.000586	CcSEcCtD
Allopurinol—Rash—Betamethasone—ankylosing spondylitis	4.6e-05	0.000584	CcSEcCtD
Allopurinol—Rash—Dexamethasone—ankylosing spondylitis	4.6e-05	0.000584	CcSEcCtD
Allopurinol—Dermatitis—Betamethasone—ankylosing spondylitis	4.6e-05	0.000584	CcSEcCtD
Allopurinol—Dermatitis—Dexamethasone—ankylosing spondylitis	4.6e-05	0.000584	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	4.59e-05	0.000582	CcSEcCtD
Allopurinol—Headache—Betamethasone—ankylosing spondylitis	4.57e-05	0.00058	CcSEcCtD
Allopurinol—Headache—Dexamethasone—ankylosing spondylitis	4.57e-05	0.00058	CcSEcCtD
Allopurinol—Asthenia—Prednisone—ankylosing spondylitis	4.56e-05	0.000579	CcSEcCtD
Allopurinol—Pain—Methotrexate—ankylosing spondylitis	4.54e-05	0.000577	CcSEcCtD
Allopurinol—Pruritus—Prednisone—ankylosing spondylitis	4.5e-05	0.000571	CcSEcCtD
Allopurinol—Feeling abnormal—Methotrexate—ankylosing spondylitis	4.38e-05	0.000556	CcSEcCtD
Allopurinol—Diarrhoea—Prednisone—ankylosing spondylitis	4.35e-05	0.000552	CcSEcCtD
Allopurinol—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	4.34e-05	0.000551	CcSEcCtD
Allopurinol—Nausea—Betamethasone—ankylosing spondylitis	4.34e-05	0.00055	CcSEcCtD
Allopurinol—Nausea—Dexamethasone—ankylosing spondylitis	4.34e-05	0.00055	CcSEcCtD
Allopurinol—Urticaria—Methotrexate—ankylosing spondylitis	4.22e-05	0.000536	CcSEcCtD
Allopurinol—Dizziness—Prednisone—ankylosing spondylitis	4.2e-05	0.000534	CcSEcCtD
Allopurinol—Abdominal pain—Methotrexate—ankylosing spondylitis	4.2e-05	0.000533	CcSEcCtD
Allopurinol—Body temperature increased—Methotrexate—ankylosing spondylitis	4.2e-05	0.000533	CcSEcCtD
Allopurinol—Vomiting—Prednisone—ankylosing spondylitis	4.04e-05	0.000513	CcSEcCtD
Allopurinol—Rash—Prednisone—ankylosing spondylitis	4.01e-05	0.000509	CcSEcCtD
Allopurinol—Dermatitis—Prednisone—ankylosing spondylitis	4e-05	0.000508	CcSEcCtD
Allopurinol—Headache—Prednisone—ankylosing spondylitis	3.98e-05	0.000505	CcSEcCtD
Allopurinol—Hypersensitivity—Methotrexate—ankylosing spondylitis	3.91e-05	0.000497	CcSEcCtD
Allopurinol—Asthenia—Methotrexate—ankylosing spondylitis	3.81e-05	0.000484	CcSEcCtD
Allopurinol—Nausea—Prednisone—ankylosing spondylitis	3.78e-05	0.000479	CcSEcCtD
Allopurinol—Pruritus—Methotrexate—ankylosing spondylitis	3.76e-05	0.000477	CcSEcCtD
Allopurinol—Diarrhoea—Methotrexate—ankylosing spondylitis	3.63e-05	0.000461	CcSEcCtD
Allopurinol—Dizziness—Methotrexate—ankylosing spondylitis	3.51e-05	0.000446	CcSEcCtD
Allopurinol—Vomiting—Methotrexate—ankylosing spondylitis	3.38e-05	0.000429	CcSEcCtD
Allopurinol—Rash—Methotrexate—ankylosing spondylitis	3.35e-05	0.000425	CcSEcCtD
Allopurinol—Dermatitis—Methotrexate—ankylosing spondylitis	3.35e-05	0.000425	CcSEcCtD
Allopurinol—Headache—Methotrexate—ankylosing spondylitis	3.33e-05	0.000422	CcSEcCtD
Allopurinol—Nausea—Methotrexate—ankylosing spondylitis	3.16e-05	0.000401	CcSEcCtD
